RNPL

Renol Polychem Share Price

 

 

Start SIP in RNPL

Start SIP
Renol Polychem live price: ₹138.8. It opened at ₹139 vs previous close ₹136; intraday high/low: ₹139/₹134. The 50 DMA stands at ₹142.21.

Renol Polychem Performance

  • Low
  • ₹134
  • High
  • ₹139
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹158
  • Open Price₹139
  • Previous Close₹136
  • Volume4,800
  • 50 DMA₹142.21
  • 100 DMA₹128.70
  • 200 DMA-

Investment Returns

  • Over 1 Month -8.53%
  • Over 3 Month -5.51%
  • Over 6 Month + 96.18%
  • Over 1 Year + 32.19%

Smart Investing Starts Here Start SIP with Renol Polychem for Steady Growth!

Invest Now

Renol Polychem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 31.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 158
  • P/B Ratio
  • 3.8
  • Average True Range
  • 5.07
  • EPS
  • 6.29
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.51
  • RSI
  • 41.6
  • MFI
  • 47.16

Renol Polychem Financials

Renol Polychem Technicals

EMA & SMA

Current Price
₹138.80
+ 2.8 (2.06%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 4
  • 20 Day
  • ₹142.17
  • 50 Day
  • ₹142.21
  • 100 Day
  • ₹128.70
  • 200 Day
  • -

Resistance and Support

137.45 Pivot Speed
  • R3 145.55
  • R2 142.40
  • R1 140.60
  • S1 135.65
  • S2 132.50
  • S3 130.70

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Renol Polychem Ltd, is India’s fastest-growing masterbatch manufacturer. With advanced twin-screw extruders, it produces high-quality color and additive masterbatches, serving plastic processors across India through efficient logistics and reliable production capabilities.

Renol Polychem Ltd has an operating revenue of Rs. 137.67 Cr. on a trailing 12-month basis. An annual revenue growth of 860% is outstanding, Pre-tax margin of 11% is healthy, ROE of 37% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 14% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -12% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 132 indicates it belongs to a poor industry group of Chemicals-Plastics and a Master Score of B is close to being the best. Overall, the stock has some strength but we want to see some buyer interest and further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Renol Polychem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-11-10 To consider Fund Raising

Renol Polychem F&O

Renol Polychem Shareholding Pattern

48.16%
0%
41.23%
10.61%

About Renol Polychem

  • NSE Symbol
  • RNPL
  • BSE Symbol
  • Managing Director
  • Mr. Bhaveshbhai Mansukhbhai Harsoda
  • ISIN
  • INE0VZX01015

Similar Stocks to Renol Polychem

Renol Polychem FAQs

Renol Polychem share price is ₹138 As on 12 March, 2026 | 01:18

The Market Cap of Renol Polychem is ₹158.2 Cr As on 12 March, 2026 | 01:18

The P/E ratio of Renol Polychem is 31.7 As on 12 March, 2026 | 01:18

The PB ratio of Renol Polychem is 3.8 As on 12 March, 2026 | 01:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23